BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34700378)

  • 1. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is
    Kwon-Chung KJ; Saijo T
    J Fungi (Basel); 2015; 1(2):154-167. PubMed ID: 27795955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
    Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
    Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
    Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
    Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central Nervous System Cryptococcosis due to
    Lizarazo J; Castañeda E
    Curr Trop Med Rep; 2022; 9(1):1-7. PubMed ID: 35378784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies neutralizing GM-CSF in HIV-negative Colombian patients infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    Res Sq; 2024 Jan; ():. PubMed ID: 38313298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
    Chan M; Lye D; Win MK; Chow A; Barkham T
    Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of Cryptococcus Meningoencephalitis].
    Miyazato A
    Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten challenges on Cryptococcus and cryptococcosis.
    Del Poeta M; Casadevall A
    Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
    Hansakon A; Ngamskulrungroj P; Angkasekwinai P
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
    Hurtado JC; Castillo P; Fernandes F; Navarro M; Lovane L; Casas I; Quintó L; Marco F; Jordao D; Ismail MR; Lorenzoni C; Martinez-Palhares AE; Ferreira L; Lacerda M; Monteiro W; Sanz A; Letang E; Marimon L; Jesri S; Cossa A; Mandomando I; Vila J; Bassat Q; Ordi J; Menéndez C; Carrilho C; Martínez MJ
    Sci Rep; 2019 May; 9(1):7493. PubMed ID: 31097746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What makes Cryptococcus gattii a pathogen?
    Bielska E; May RC
    FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.
    Byrnes EJ; Li W; Ren P; Lewit Y; Voelz K; Fraser JA; Dietrich FS; May RC; Chaturvedi S; Chaturvedi V; Heitman J
    PLoS Pathog; 2011 Sep; 7(9):e1002205. PubMed ID: 21909264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.
    Davis MJ; Moyer S; Hoke ES; Sionov E; Mayer-Barber KD; Barber DL; Cai H; Jenkins L; Walter PJ; Chang YC; Kwon-Chung KJ
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213551
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Applen Clancey S; Ciccone EJ; Coelho MA; Davis J; Ding L; Betancourt R; Glaubiger S; Lee Y; Holland SM; Gilligan P; Sung J; Heitman J
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.